1006 related articles for article (PubMed ID: 17341655)
1. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
6. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.
Carnero A; Blanco-Aparicio C; Renner O; Link W; Leal JF
Curr Cancer Drug Targets; 2008 May; 8(3):187-98. PubMed ID: 18473732
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
[TBL] [Abstract][Full Text] [Related]
8. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
Marsh J; Mukherjee P; Seyfried TN
Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
[TBL] [Abstract][Full Text] [Related]
9. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
10. The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer.
Assinder SJ; Dong Q; Kovacevic Z; Richardson DR
Biochem J; 2009 Jan; 417(2):411-21. PubMed ID: 19099539
[TBL] [Abstract][Full Text] [Related]
11. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells.
van Nimwegen MJ; Huigsloot M; Camier A; Tijdens IB; van de Water B
Mol Pharmacol; 2006 Oct; 70(4):1330-9. PubMed ID: 16825486
[TBL] [Abstract][Full Text] [Related]
13. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX
Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355
[TBL] [Abstract][Full Text] [Related]
14. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
[TBL] [Abstract][Full Text] [Related]
15. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
[TBL] [Abstract][Full Text] [Related]
16. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer.
Kim D; Cheng GZ; Lindsley CW; Yang H; Cheng JQ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1250-8. PubMed ID: 16370391
[TBL] [Abstract][Full Text] [Related]
17. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.
Osman I; Dai J; Mikhail M; Navarro D; Taneja SS; Lee P; Christos P; Shen R; Nanus DM
Cancer; 2006 Dec; 107(11):2628-36. PubMed ID: 17083125
[TBL] [Abstract][Full Text] [Related]
18. Phosphatase PTEN in chicken muscle is regulated during ontogenesis.
Vaudin P; Dupont J; Duchêne S; Audouin E; Crochet S; Berri C; Tesseraud S
Domest Anim Endocrinol; 2006 Aug; 31(2):123-40. PubMed ID: 16307863
[TBL] [Abstract][Full Text] [Related]
19. Casein kinase Iepsilon down-regulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells.
Okamura A; Iwata N; Tamekane A; Yakushijin K; Nishikawa S; Hamaguchi M; Fukui C; Yamamoto K; Matsui T
Life Sci; 2006 Feb; 78(14):1624-9. PubMed ID: 16274701
[TBL] [Abstract][Full Text] [Related]
20. The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target.
Goswami A; Ranganathan P; Rangnekar VM
Cancer Res; 2006 Mar; 66(6):2889-92. PubMed ID: 16540633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]